Laurence Malard

Population pharmacokinetics of erlotinib and its pharmacokinetic/pharmacodynamic relationships in head and neck squamous cell carcinoma

Fabienne Thomas, Philippe Rochaix, Mélanie White‐Koning et al. · European Journal of Cancer · 2009 · 82 citations

Medicine, Pharmacology, Pharmacokinetic/pharmacodynamic Relationships +9

Cystatin C as a New Covariate to Predict Renal Elimination of Drugs

Fabienne Thomas, Sophie S ronie-Vivien, Laurence Gladieff et al. · Clinical Pharmacokinetics · 2005 · 52 citations

Urology, Renal Function, Medicine +9

Serum Cystatin C is a Better Marker of Topotecan Clearance than Serum Creatinine

Antje Hoppe, Sophie Séronie-Vivien, Fabienne Thomas et al. · Clinical Cancer Research · 2005 · 34 citations

Should therapeutic drug monitoring of the unbound fraction of imatinib and its main active metabolite N-desmethyl-imatinib be developed?

Peggy Gandia, Cécile Arellano, Thierry Lafont et al. · Cancer Chemotherapy and Pharmacology · 2012 · 31 citations

Therapeutic Drug Monitoring, Medicinal Chemistry, Biochemistry +14

Urinary cystatin C can improve the renal safety follow-up of tenofovir-treated patients

Acil Jaafar, Sophie Séronie-Vivien, Laurence Malard et al. · AIDS · 2008 · 29 citations

Curve Analysis, Renal Monitoring, Tenofovir-treated Patients +13